268 related articles for article (PubMed ID: 21394599)
61. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
62. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
63. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
64. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
65. PET/CT in gynecologic malignancies.
Brunetti J
Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
[TBL] [Abstract][Full Text] [Related]
66. Gynecologic oncologic imaging with PET/CT.
Grant P; Sakellis C; Jacene HA
Semin Nucl Med; 2014; 44(6):461-78. PubMed ID: 25362236
[TBL] [Abstract][Full Text] [Related]
67. Clinical impact of pre-treatment FDG-PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women.
Sponholtz SE; Mogensen O; Hildebrandt MG; Jensen PT
Acta Obstet Gynecol Scand; 2020 Feb; 99(2):186-195. PubMed ID: 31505027
[TBL] [Abstract][Full Text] [Related]
68. Diffuse peritoneal carcinomatosis and Sister Mary Joseph nodule in ovarian carcinoma - exquisite demonstration of the peritoneal reflections on [18F]FDG PET/CT.
Robinson E; Nawwar A; Searle J; Lyburn I
Nucl Med Rev Cent East Eur; 2023; 26(0):153-155. PubMed ID: 37991329
[TBL] [Abstract][Full Text] [Related]
69. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma.
Lee EYP; An H; Tse KY; Khong PL
AJR Am J Roentgenol; 2020 Aug; 215(2):305-312. PubMed ID: 32551907
[No Abstract] [Full Text] [Related]
70. Gastric recurrence of a primary colon plasmacytoma: staging and evaluating response to therapy with 18F-FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Lisbona R
Br J Radiol; 2012 Jan; 85(1009):e4-9. PubMed ID: 22190759
[TBL] [Abstract][Full Text] [Related]
71. Validation of
Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
[TBL] [Abstract][Full Text] [Related]
72. Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.
Li J; Yan R; Lei J; Jiang C
Abdom Imaging; 2015 Oct; 40(7):2660-6. PubMed ID: 25893503
[TBL] [Abstract][Full Text] [Related]
73. Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior.
Treglia G; Caporale N; Rufini V; Callea F; Locatelli F; Giordano A
Clin Nucl Med; 2013 Jan; 38(1):e35-7. PubMed ID: 23242062
[TBL] [Abstract][Full Text] [Related]
74. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
[TBL] [Abstract][Full Text] [Related]
75. Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT.
Lee DH; Yoon JK; Lee SJ; Jo KS; Yoon SH; An YS
Clin Nucl Med; 2014 Apr; 39(4):349-51. PubMed ID: 23640230
[TBL] [Abstract][Full Text] [Related]
76. A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT.
Li X; Liu S; Yao S; Wang M
Clin Nucl Med; 2015 Mar; 40(3):282-5. PubMed ID: 25608160
[TBL] [Abstract][Full Text] [Related]
77. Gynecological cancers.
Avril N; Gourtsoyianni S; Reznek R
Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
[TBL] [Abstract][Full Text] [Related]
78. FDG-PET/MRI for the preoperative diagnosis and staging of peritoneal carcinomatosis: a prospective multireader pilot study.
Vietti Violi N; Gavane S; Argiriadi P; Law A; Heiba S; Bekhor EY; Babb JS; Ghesani M; Labow DM; Taouli B
Abdom Radiol (NY); 2023 Dec; 48(12):3634-3642. PubMed ID: 36308554
[TBL] [Abstract][Full Text] [Related]
79. IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
Vadi SK; Parihar AS; Kumar R; Singh H; Mittal BR; Bal A; Sinha SK
Clin Nucl Med; 2018 Jul; 43(7):e247-e249. PubMed ID: 29762245
[TBL] [Abstract][Full Text] [Related]
80. FDG PET/CT in serous psammocarcinoma of the ovary.
Dong A; Wang Y; Zuo C
Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
